139 related articles for article (PubMed ID: 37199218)
21. [Gene mutation and clinical phenotype analysis of patients with Noonan syndrome and hypertrophic cardiomyopathy].
Liu XH; Ding WW; Han L; Liu XR; Xiao YY; Yang J; Mo Y
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):780-784. PubMed ID: 29050118
[No Abstract] [Full Text] [Related]
22. Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations.
Calcagni G; Digilio MC; Marino B; Tartaglia M
Orphanet J Rare Dis; 2019 Jul; 14(1):163. PubMed ID: 31277675
[TBL] [Abstract][Full Text] [Related]
23. Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.
Xu S; Fan Y; Sun Y; Wang L; Gu X; Yu Y
BMC Med Genomics; 2017 Oct; 10(1):62. PubMed ID: 29084544
[TBL] [Abstract][Full Text] [Related]
24. Differentiating primary sarcomeric hypertrophic cardiomyopathy from Noonan syndrome: can the electrocardiogram be of use?
Hauptmeijer RWL; Lippert L; Ten Cate FEAU; Fejzic Z; Leenders E; Wolf CM; Draaisma JMT
Cardiol Young; 2024 Mar; 34(3):597-603. PubMed ID: 37649442
[TBL] [Abstract][Full Text] [Related]
25. Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
Hudsmith LE; Petersen SE; Francis JM; Robson MD; Watkins H; Neubauer S
Int J Cardiovasc Imaging; 2006; 22(3-4):493-5. PubMed ID: 16267621
[TBL] [Abstract][Full Text] [Related]
26. In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
Wang J; Chandrasekhar V; Abbadessa G; Yu Y; Schwartz B; Kontaridis MI
PLoS One; 2017; 12(6):e0178905. PubMed ID: 28582432
[TBL] [Abstract][Full Text] [Related]
27. Hypertrophic obstructive cardiomyopathy as a manifestation of a cardiocutaneous syndrome (Noonan syndrome).
Pongratz G; Friedrich M; Unverdorben M; Kunkel B; Bachmann K
Klin Wochenschr; 1991 Dec; 69(20):932-6. PubMed ID: 1795500
[TBL] [Abstract][Full Text] [Related]
28. Noonan Syndrome With Multiple Lentigines.
Martinez-Molina M; Fabregat-Pratdepadua M; Bielsa Marsol I
Actas Dermosifiliogr; 2024 Apr; 115(4):414-416. PubMed ID: 36273552
[No Abstract] [Full Text] [Related]
29. Coronary artery dilatation in LEOPARD syndrome. A child case and literature review.
Iwasaki Y; Horigome H; Takahashi-Igari M; Kato Y; Razzaque MA; Matsuoka R
Congenit Heart Dis; 2009; 4(1):38-41. PubMed ID: 19207402
[TBL] [Abstract][Full Text] [Related]
30. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S
Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
[TBL] [Abstract][Full Text] [Related]
32. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.
Pandit B; Sarkozy A; Pennacchio LA; Carta C; Oishi K; Martinelli S; Pogna EA; Schackwitz W; Ustaszewska A; Landstrom A; Bos JM; Ommen SR; Esposito G; Lepri F; Faul C; Mundel P; López Siguero JP; Tenconi R; Selicorni A; Rossi C; Mazzanti L; Torrente I; Marino B; Digilio MC; Zampino G; Ackerman MJ; Dallapiccola B; Tartaglia M; Gelb BD
Nat Genet; 2007 Aug; 39(8):1007-12. PubMed ID: 17603483
[TBL] [Abstract][Full Text] [Related]
33. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.
Thaman R; Gimeno JR; Reith S; Esteban MT; Limongelli G; Murphy RT; Mist B; McKenna WJ; Elliott PM
J Am Coll Cardiol; 2004 Jul; 44(2):398-405. PubMed ID: 15261938
[TBL] [Abstract][Full Text] [Related]
34. Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations.
Digilio MC; Pacileo G; Sarkozy A; Limongelli G; Conti E; Cerrato F; Marino B; Pizzuti A; Calabrò R; Dallapiccola B
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):95-8. PubMed ID: 14991917
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular abnormalities in Noonan syndrome: the clinical findings and treatments.
Ishizawa A; Oho S; Dodo H; Katori T; Homma SI
Acta Paediatr Jpn; 1996 Feb; 38(1):84-90. PubMed ID: 8992869
[TBL] [Abstract][Full Text] [Related]
36. RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome.
Zheng J; Peng L; Cheng R; Li Z; Xie J; Huang E; Cheng J; Zhao Q
Mol Genet Genomic Med; 2024 Jan; 12(1):e2290. PubMed ID: 37787490
[TBL] [Abstract][Full Text] [Related]
37. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines.
Nishi E; Mizuno S; Nanjo Y; Niihori T; Fukushima Y; Matsubara Y; Aoki Y; Kosho T
Am J Med Genet A; 2015 Feb; 167A(2):407-11. PubMed ID: 25423878
[TBL] [Abstract][Full Text] [Related]
38. A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome.
Sarkozy A; Obregon MG; Conti E; Esposito G; Mingarelli R; Pizzuti A; Dallapiccola B
Eur J Hum Genet; 2004 Dec; 12(12):1069-72. PubMed ID: 15470362
[TBL] [Abstract][Full Text] [Related]
39. Atypical, severe hypertrophic cardiomyopathy in a newborn presenting Noonan syndrome harboring a recurrent heterozygous MRAS variant.
Pires LVL; Bordim RA; Maciel MBR; Tanaka ACS; Yamamoto GL; Honjo RS; Kim CA; Bertola DR
Am J Med Genet A; 2021 Oct; 185(10):3099-3103. PubMed ID: 34080768
[TBL] [Abstract][Full Text] [Related]
40. Red blood cell distribution width and maximum left ventricular wall thickness predict poor outcomes in patients with hypertrophic cardiomyopathy.
Li J; Gao W; Liu J; Zhang X; Tao J; Zhang G
Echocardiography; 2022 Feb; 39(2):278-285. PubMed ID: 35066909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
